(R)-TERT-BUTYL 4-(1-AMINOETHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 5g

iScope IS.1159-PLPHi Biocular for phase contrast with Plan phase IOS objectives, Rackless cross table and Photo attachment (infinity - ergonomic tilting head)

[(2-methyl-1H-benzimidazol-5-yl)methyl]amine dihydrochloride hydrate, 95.0%, 250mg

4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM), 97.0%, 500g

2-Chloro-6-fluorobenzenethiol, 250mg

(4-(1-Aminocyclopropyl)phenyl)boronic acid hydrochloride, 97%, 250mg

3-O-ACETYL-4,6-O-ISOPROPYLIDENE-D-GLUCAL, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hex-5-enoic acid, 97%, 10g

2-(2-Bromophenyl)piperazine, 95%, 1g

H-DL-Glu(Ome)-OH, 25g

5,10,15,20-Tetrakis(4-hydroxyphenyl)porphyrin, 98%, 100mg

Methyl 5-(ethylsulfonyl)-2-methoxybenzoate, 95.0%, 25g

1-(Cyclopropylsulfonyl)-1,4-diazepane, 95%, 5g